LATIN AMERICA
PROBIOMED ’ s radar . “ We are looking forward to expand our presence into countries where our low-cost products create a difference ,” the CEO said .
Clear , sequenced goals
PROBIOMED has established four key priorities for the short term :
Company Information
NAME
PROBIOMED , S . A . de C . V .
INDUSTRY
Pharmaceutics , biotech , biosimilar medical products
• Become compliant with new regulations for biosimilars
• Expand sales and international presence · Increase sales figures and patients under treatment in Mexico
• Continue with biosimilar medical products R & D , focused on chronic and degenerative conditions
“ We have five of our own drugs under development and other licensed products to launch in upcoming years . These developments are focused on therapeutic aid , mainly for oncology and rheumatoid arthritis ,” Sánchez said .
HEADQUARTERS
México , Distrito Federal , México
FOUNDED
1970
EMPLOYEES
1,400 +
REVENUE
US $ 100 million est .
WEBSITE www . probiomed . com . mx www . probiomed . com . mx 91